tiprankstipranks
Trending News
More News >
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
Advertisement

Amylyx Pharmaceuticals Inc (AMLX) Ratios

Compare
641 Followers

Amylyx Pharmaceuticals Inc Ratios

AMLX's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, AMLX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
13.70 5.66 8.20 5.84 1.86
Quick Ratio
13.70 5.20 7.99 5.84 1.86
Cash Ratio
8.73 2.07 1.34 2.89 1.76
Solvency Ratio
-4.84 0.60 -3.89 -0.34 -0.55
Operating Cash Flow Ratio
-5.99 0.15 -3.86 -4.30 -5.01
Short-Term Operating Cash Flow Coverage
-157.44 0.00 -88.17 0.00 0.00
Net Current Asset Value
$ 322.64M$ 380.64M$ 331.29M$ -155.27M$ -67.19M
Leverage Ratios
Debt-to-Assets Ratio
0.02 <0.01 0.02 0.00 0.10
Debt-to-Equity Ratio
0.02 <0.01 0.02 0.00 -0.02
Debt-to-Capital Ratio
0.02 <0.01 0.02 0.00 -0.02
Long-Term Debt-to-Capital Ratio
0.01 0.00 0.00 0.00 -0.02
Financial Leverage Ratio
1.09 1.19 1.15 -0.70 -0.21
Debt Service Coverage Ratio
-157.83 0.00 -31.85 0.00 -18.16
Interest Coverage Ratio
0.00 0.00 -46.92 0.00 -17.05
Debt to Market Cap
<0.01 0.00 <0.01 0.00 <0.01
Interest Debt Per Share
0.06 0.06 0.16 0.00 0.07
Net Debt to EBITDA
1.41 -4.16 0.28 0.61 0.29
Profitability Margins
Gross Profit Margin
145.26%93.32%86.54%81.75%-3683.69%
EBIT Margin
18030.08%10.19%-905.72%-29013.33%-6000.77%
EBITDA Margin
23378.95%10.48%-903.53%-28995.09%-6000.62%
Operating Profit Margin
23660.30%10.19%-905.72%-29013.33%-6000.77%
Pretax Profit Margin
22543.91%14.26%-888.89%-30852.98%-6504.62%
Net Profit Margin
22448.42%12.94%-892.38%-30834.74%-6898.00%
Continuous Operations Profit Margin
17277.59%12.94%-892.38%-30852.98%-6504.62%
Net Income Per EBT
99.58%90.74%100.39%99.94%106.05%
EBT Per EBIT
95.28%139.93%98.14%106.34%108.40%
Return on Assets (ROA)
-41.15%9.52%-50.68%-83.21%-317.90%
Return on Equity (ROE)
-68.95%11.37%-58.24%58.13%67.20%
Return on Capital Employed (ROCE)
-46.70%8.91%-58.39%-93.73%-575.46%
Return on Invested Capital (ROIC)
-46.36%8.04%-57.93%-93.68%-610.27%
Return on Tangible Assets
-41.15%9.52%-50.68%-83.21%-317.90%
Earnings Yield
-12.99%4.98%-8.07%-8.40%-4.39%
Efficiency Ratios
Receivables Turnover
-5.04 9.51 1.45 0.00 0.00
Payables Turnover
0.03 1.15 0.48 0.01 6.81
Inventory Turnover
0.00 0.66 0.31 0.00 0.00
Fixed Asset Turnover
-0.11 59.40 2.73 0.60 4.30
Asset Turnover
>-0.01 0.74 0.06 <0.01 0.05
Working Capital Turnover Ratio
>-0.01 1.06 0.11 <0.01 0.26
Cash Conversion Cycle
-13.89K 271.70 679.61 -30.69K -53.62
Days of Sales Outstanding
-72.45 38.39 251.31 0.00 0.00
Days of Inventory Outstanding
0.00 549.82 1.19K 0.00 0.00
Days of Payables Outstanding
13.82K 316.51 763.05 30.69K 53.62
Operating Cycle
-72.45 588.21 1.44K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.65 0.18 -2.70 -1.29 -0.65
Free Cash Flow Per Share
-1.66 0.16 -2.74 -1.30 -0.65
CapEx Per Share
<0.01 0.02 0.04 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 0.90 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-2.15K 9.60 -71.21 -211.90 -243.03
Capital Expenditure Coverage Ratio
-2.15K 9.60 -71.21 -211.90 -243.03
Operating Cash Flow Coverage Ratio
-26.02 2.81 -28.66 0.00 -25.75
Operating Cash Flow to Sales Ratio
232.25 0.03 -8.09 -262.45 -56.46
Free Cash Flow Yield
-13.45%1.08%-7.42%-7.19%-3.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.70 20.09 -12.39 -11.90 -22.76
Price-to-Sales (P/S) Ratio
-1.73K 2.60 110.55 3.67K 1.57K
Price-to-Book (P/B) Ratio
3.46 2.28 7.22 -6.92 -15.29
Price-to-Free Cash Flow (P/FCF) Ratio
-7.43 92.69 -13.47 -13.91 -27.69
Price-to-Operating Cash Flow Ratio
-7.44 83.03 -13.66 -13.98 -27.80
Price-to-Earnings Growth (PEG) Ratio
-0.27 -0.16 -0.13 -0.13 -0.11
Price-to-Fair Value
3.46 2.28 7.22 -6.92 -15.29
Enterprise Value Multiple
-5.98 20.65 -11.96 -12.05 -25.87
Enterprise Value
929.57M 823.73M 2.40B 995.41M 1.01B
EV to EBITDA
-5.98 20.65 -11.96 -12.05 -25.87
EV to Sales
-1.40K 2.16 108.02 3.49K 1.55K
EV to Free Cash Flow
-6.02 77.14 -13.17 -13.25 -27.38
EV to Operating Cash Flow
-6.02 69.11 -13.35 -13.31 -27.49
Tangible Book Value Per Share
3.56 6.45 5.12 -2.61 -1.18
Shareholders’ Equity Per Share
3.56 6.45 5.12 -2.61 -1.18
Tax and Other Ratios
Effective Tax Rate
<0.01 0.09 >-0.01 <0.01 -0.06
Revenue Per Share
>-0.01 5.66 0.33 <0.01 0.01
Net Income Per Share
-1.60 0.73 -2.98 -1.52 -0.79
Tax Burden
1.00 0.91 1.00 1.00 1.06
Interest Burden
1.25 1.40 0.98 1.06 1.08
Research & Development to Revenue
-138.26 0.34 4.20 154.53 37.84
SG&A to Revenue
-21.65 0.47 5.72 136.61 23.17
Stock-Based Compensation to Revenue
-42.11 0.10 0.98 11.00 0.37
Income Quality
1.03 0.24 0.91 0.85 0.87
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis